___

• 1. Simonian NA, Coyle ST. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83- 106, 1996
• 2. Multhaup G. Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, Beyreuther K. Reactive oxygen species and AlzheimerÕs Disease. Biochemical Pharmacology 54; 533-39, 1997
• 3. Yankner B, Dawes L, Fisher S, Villa- Kamaroff L, Oster-Granite M, et al. Neurotoxicity of a fragment of the amyloid precursor associated with AlzheimerÕs disease. Science 245; 417- 20, 1989
• 4. Behl C, Davis J, Cole GM, Schubert D. Vitamin E protects nerve cells from amyloid b protein toxicity. Biochem Biophy Res Commun 186; 944-50, 1992 5. Behl C, Davis J, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid b protein toxicity. Cell 77; 817-27, 1994
• 6. Selkoe D. The molecular pathology of Alzheimer's disease. Neuron 6;487- 498, 1991
• 7. Dyrks T, Dyrks E, Hartman T, Masters C, Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal catalyzed oxidation. J Biol Chem 267; 18210-17, 1992
• 8. Palmer A, Burris M. Selective increase in lipid peroxidation in the inferior temporal cortex in AlzheimerÕs disease. Brain Res 645; 338-42, 1994
• 9. Markesbery WR. Oxidative stress hypothesis in AlzheimerÕs disease. Free Radic Biol Med 23; 134-47, 1997
• 10. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. No evidence for systemic oxidant stress in ParkinsonÕs or AlzheimerÕs disease. Mov Disord 10; 566-73, 1995
• 11. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Altered plasma antioxidant status in subjects with AlzheimerÕs disease and vascular dementia. Int J Geriatr Psychiatry 13; 840-5, 1998
• 12. De Leo ME, Borrello S, Passantino M, Palazzotti B, Mordente A, Daniele A, Filippini V, Galeotti T, Masullo C. Oxidative stress and overexpression of mangenese superoxide dismutase in patients with AD. Nurosci Lett 250; 173-6, 1998
• 13. Davidson P, Ekman R, Blennow K. A new procedure for detecting brain specific proteins in cerebrospinal fluid. Journal of Neural Transmission 104; 711-20, 1997
• 14. Davidson P, Ekman R, Blennow K. A new procedure for detecting brain specific proteins in cerebrospinal fluid. Journal of Neural Transmission 104: 711-720, 1997
• 15. Malloy MF, Cummings JL, Coffey CE, Duffy J, Fink M, Lauterbach EC, Lovell M, Royall D, Salloway S. Cognitive screening instruments in neuropsychiatry: a report of the committee on research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 9: 189- 97, 1997
• 16. Durak I, Karabacak HI, BŸyŸkkoak S, ‚imen B, Kamaz M, …meroÛlu E, …ztŸrk HS. Impaired Antioxidant Defense System in Kidney Tissues from Rabbits Treated with Cyclosporine. Nephron 78; 207-11, 1998
• 17. Miller N, Rice-Evans C, Davies MJ, Gopinathan V and Milner A.A Novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science 84;407-12, 1993
• 18. Van Ye TM, Roza AM, Pieper GM, Henderson JRJ, Johnson CP, Adams MB. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J Surg Res 55;553-8, 1993
• 19. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function: a review. Clin Chem Lab Med 37; 389-95, 1999
• 20. Bland JM, Altman DG. Statistical methods for assessing agreement between measurement Biochim Clin 11:399-404, 1987
• 21. Richardson JS. Free radicals in genesis of AlzheimerÕs disease. Ann NY Acad Sci 685;73-6, 1993
• 22. Marcus DL, Thomas C, Rodrigues C, Simberkoff T, Tsai JS, Strafaci JA, Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in AlzheimerÕs disease. Exp Neurol 150;40-4, 1998
• 23. Arai H. Biological markers for the clinical diagnosis of AlzheimerÕs Disease. Tohoku J Exp. Med 179; 65- 79, 1996
• 24. Valanti G. Neuropeptide changes in Dementia: Pathogenetic Implications and diagnostic value. Gerontology 42: 241-256, 1996
• 25. Wahlund LO. Biological markers and diagnostic investigations in AlzheimerÕs disease. Acta Neurol Scand; Supplement 165: 85-91, 1996
• 26. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Altered plasma antioxidant status in subjects with AlzheimerÕs disease and vascular dementia. Int J Geriatr Psychiatry 13;840-5, 1998
• 27. Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B. Low plasma Vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 13;749-54, 1998